Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GDA | Q9Y2T3 | 2/20 | 0.48 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.48 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.42 |
| ▸ | CDK2 | P24941 | 4/20 | 0.37 |
| ▸ | DPP4 | P27487 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | CDK1 | P06493 | 3/20 | 0.34 |
| ▸ | CCNB1 | P14635 | 3/20 | 0.34 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.34 |
| ▸ | MAP3K5 | Q99683 | 1/20 | 0.34 |
| ▸ | DHFR | P00374 | 2/20 | 0.33 |
| ▸ | XDH | P47989 | 2/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.32 |
| ▸ | HBB | P68871 | 1/20 | 0.32 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2,6-Diaminopurine SCHEMBL29444619 | 1.00 | GDA (0.48) | GDAPDPK1ADORA2ACDK2DPP4 | |
| 2,6-Diaminopurine SCHEMBL8757968 | 0.98 | GDA (0.47) | GDAPDPK1ADORA2ACDK2DPP4 | |
| 2,6-Diaminopurine SCHEMBL6423146 | 0.98 | GDA (0.47) | GDAPDPK1ADORA2ACDK2DPP4 | |
| 2,6-Diaminopurine SCHEMBL5017251 | 0.91 | PDPK1 (0.42) | GDAPDPK1ADORA2ACDK2CDK1 | |
| 2,6-Diaminopurine SCHEMBL1033680 | 0.91 | GDA (0.42) | GDAPDPK1ADORA2ACDK2DPP4 | |
| 2,6-Diaminopurine SCHEMBL7659157 | 0.89 | GDA (0.41) | GDAPDPK1ADORA2ACDK2DPP4 | |
| 2,6-Diaminopurine SCHEMBL1074475 | 0.89 | GDA (0.41) | GDAPDPK1ADORA2ACDK2DPP4 | |
| 2,6-Diaminopurine SCHEMBL1931238 | 0.86 | PDPK1 (0.39) | GDAPDPK1ADORA2ACDK2DPP4 | |
| 2,6-Diaminopurine SCHEMBL1825527 | 0.83 | ALDH1A1 (0.50) | GDAPDPK1ALDH1A1XDHUSP2 | |
| SCHEMBL8485064 | 0.82 | PDPK1 (0.36) | GDAPDPK1CDK2DPP4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 64129 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260146273-A1 | METHOD FOR ONE-POT BIOSYNTHESIS OF ARABINONUCLEOSIDE, AND COMPOSITION | ASYMCHEM LIFE SCIENCE (TIANJIN) CO., LTD. (CN) | 2026-05-28 | — | — | US | claimed |
| US-20260144879-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | AI-BIOPHARMA (FR) | 2026-05-28 | — | — | US | claimed |
| WO-2026106497-A2 | FUNCTIONALIZED CIRCULAR RNA AND METHODS AND INTERMEDIATES FOR THEIR PRODUCTION | SIEĆ BADAWCZA ŁUKASIEWICZ – PORT POLSKI OSRODEK ROZWOJU TECHNOLOGII (PL) | 2026-05-21 | — | — | WO | claimed |
| US-12630827-B2 | Antisense oligonucleotides targeting SCN2A for the treatment of SCN1A encephalopathies | ROGCON, INC. (US) | 2026-05-19 | — | — | US | claimed |
| US-20260124274-A1 | METHODS OF INCREASING READTHROUGH OF A PREMATURE TERMINATION CODON | UNIV RAMOT (IL) | 2026-05-07 | — | — | US | claimed |
| US-20260117116-A1 | COMPOSITION AND METHOD FOR HYDRAULIC FRACTURING AND EVALUATION AND DIAGNOSTICS OF HYDRAULIC FRACTURES USING INFUSED POROUS CERAMIC PROPPANT | CARBO CERAMICS INC (US) | 2026-04-30 | — | — | US | claimed |
| WO-2026090528-A2 | CIRCULARLY STRUCTURED GUIDE RNAS FOR CRISPR GENOME EDITING | UNIVERSITY OF MASSACHUSETTS (US) | 2026-04-30 | — | — | WO | claimed |
| US-20260117285-A1 | COMPOSITIONS AND METHODS FOR IMPROVING LIBRARY ENRICHMENT | ILLUMINA INC (US) | 2026-04-30 | — | — | US | claimed |
| US-20260109977-A1 | MODIFIED RNA FOR INCREASING PROTEIN EXPRESSION | TRILINK BIOTECHNOLOGIES, LLC (US) | 2026-04-23 | — | — | US | claimed |
| US-12605400-B2 | Oligomeric nucleic acid molecule, and application thereof in an acute intermittent porphyria treatment | RACTIGEN THERAPEUTICS (CN) | 2026-04-21 | — | — | US | claimed |
| EP-0269947-A1 | Antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives | INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY OF THE ACADEMY OF SCIENCES OF THE CZECH REPUBLIC (CS) | 1988-06-08 | — | — | EP | claimed |
| EP-0254268-A2 | Fluorinated nucleosides,their preparation and their pharmaceutical use against AIDS | THE WELLCOME FOUNDATION LIMITED (GB) | 1988-01-27 | — | — | EP | claimed |
| EP-0117777-B1 | COMPOUNDS CONTAINING AN OLIGONUCLEOTIDE BONDED TO AN INTERCALLATING AGENT, A PROCESS FOR THEIR PREPARATION AND THEIR APPLICATION | Etablissement Public dit: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1987-12-23 | — | — | EP | claimed |
| US-4670424-A | Cyclic pyrophosphates of purine and pyrimidine acyclonucleosides | MERCK & CO., INC. (US) | 1987-06-02 | — | — | US | claimed |
| EP-0214908-A1 | Compounds containing an oligonucleotide sequence linked to an intercalating agent and to an activable chemical group, their synthesis and applications to artificial sequence-specific nucleases | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1987-03-18 | — | — | EP | claimed |
| WO-1986003678-A1 | COMPOSITION AND METHOD FOR TREATMENT OF TUMORS WITH UDPG | MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (US) | 1986-07-03 | — | — | WO | claimed |
| EP-0169787-A1 | Use of oligonucleotides bonded to an intercalating agent as drugs | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1986-01-29 | — | — | EP | claimed |
| EP-0138656-A1 | Cyclic pyrophosphates of purine and pyrimidine acyclonucleosides, their preparation and their application in anti-viral compositions | MERCK & CO. INC. (US) | 1985-04-24 | — | — | EP | claimed |
| US-4060616-A | VIRICIDE | BURROUGHS WELLCOME CO. (US) | 1977-11-29 | — | — | US | claimed |
| US-4002532-A | BINDING ANTIBODIES | WELTMAN JOEL K | 1977-01-11 | — | — | US | claimed |